These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16832090)

  • 21. Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.
    Earley CJ; Uhl GR; Clemens S; Ferré S
    Sleep Med; 2017 Mar; 31():71-77. PubMed ID: 27539027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice.
    Clemens S; Hochman S
    J Neurosci; 2004 Dec; 24(50):11337-45. PubMed ID: 15601940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian effects of dopaminergic treatment in restless legs syndrome.
    Garcia-Borreguero D; Serrano C; Larrosa O; Granizo JJ
    Sleep Med; 2004 Jul; 5(4):413-20. PubMed ID: 15223002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of D2 receptor mediated regulation of dopamine synthesis in A11 diencephalospinal neurons in male and female mice.
    Pappas SS; Behrouz B; Janis KL; Goudreau JL; Lookingland KJ
    Brain Res; 2008 Jun; 1214():1-10. PubMed ID: 18462709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathophysiology of restless legs syndrome].
    Monaca C
    Presse Med; 2010 May; 39(5):587-91. PubMed ID: 20346613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study.
    Walters AS; Ondo WG; Zhu W; Le W
    J Neurol Sci; 2009 Apr; 279(1-2):62-5. PubMed ID: 19167016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Restless-legs syndrome].
    Karroum E; Konofal E; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In restless legs syndrome, the neural substrates of the sensorimotor symptoms are also normally involved in upright standing posture and biped walking.
    Akpinar S
    Med Hypotheses; 2009 Aug; 73(2):169-76. PubMed ID: 19394150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
    Varga LI; Ako-Agugua N; Colasante J; Hertweck L; Houser T; Smith J; Watty AA; Nagar S; Raffa RB
    J Clin Pharm Ther; 2009 Oct; 34(5):493-505. PubMed ID: 19744006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease and RLS: the dopaminergic bridge.
    Rye DB
    Sleep Med; 2004 May; 5(3):317-28. PubMed ID: 15165542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the pathway of an animal model for restless legs syndrome..
    Manconi M; Hutchins W; Feroah TR; Zucconi M; Ferini-Strambi L
    Neurol Sci; 2007 Jan; 28 Suppl 1():S53-60. PubMed ID: 17235432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous silent period in patients with restless leg syndrome.
    Han JK; Oh K; Kim BJ; Koh SB; Kim JY; Park KW; Lee DH
    Clin Neurophysiol; 2007 Aug; 118(8):1705-10. PubMed ID: 17587642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.
    Lyu S; DeAndrade MP; Mueller S; Oksche A; Walters AS; Li Y
    Behav Brain Res; 2019 Nov; 374():112123. PubMed ID: 31376441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).
    Allen R
    Sleep Med; 2004 Jul; 5(4):385-91. PubMed ID: 15222997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can botulinum toxin put the restless legs syndrome to rest?
    Lim EC; Seet RC
    Med Hypotheses; 2007; 69(3):497-501. PubMed ID: 17363179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.